Zealand reports results for the first three months of 2017 (unaudited)

Copenhagen, May 17, 2017 – Zealand Pharma A/S (“Zealand”) (Company reg. No. 20 04 50 78) announces financial results in line with guidance and continued positive progress for its product portfolio and business for the three-month period from January 1 to March 31, 2017.